Globus Medical Inc. (NYSE: GMED) has acquired Higgs Boson Health, a digital healthcare company incubated at Duke University and based in Durham, North Carolina. The deal, announced on Aug. 26, 2026, expands Globus Medical’s focus beyond musculoskeletal devices into digital solutions for surgical intelligence and patient-care ecosystems.
Terms of the transaction were not disclosed. Higgs Boson Health employs teams of software developers and AI scientists who will join Globus Medical’s operations, according to the acquiring company. The integration aims to strengthen Globus Medical’s digital healthcare initiatives, including the development of a seamless environment for patient data, outcomes tracking, and continuous learning across surgical procedures.
David Paul, founder and executive chairman of Globus Medical, said the acquisition brings experienced talent in software and AI to support the company’s vision of a connected digital healthcare system. Keith Pfeil, president and CEO, added that Higgs Boson’s technology will be incorporated into the company’s surgical intelligence pillar, enabling closed-loop analytics that link patient outcomes with procedural data for iterative improvement.
Globus Medical, headquartered in Audubon, Pennsylvania, designs and manufactures products for spine, orthopedic trauma, joint reconstruction, biomaterials, and enabling technologies. The acquisition reflects a broader trend among medical technology firms to integrate digital tools and artificial intelligence into traditional device-based care models.
